Bumper Offer - Urjas oil Just @ Rs. 1
Neugaba 75 Mg Capsule is a commercial drug that is prescribed in the form of Capsule. It is primarily used for the treatment of Neuropathic Pain, Epilepsy, Anxiety. Other than this, Neugaba 75 Mg Capsule has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Neugaba 75 Mg Capsule depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Neugaba 75 Mg Capsule can also lead to other problems, which have been listed below. Such side effects of Neugaba 75 Mg Capsule normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Neugaba 75 Mg Capsule's effect during pregnancy is Moderate and Severe while nursing. Warnings related to Neugaba 75 Mg Capsule's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Neugaba 75 Mg Capsule contraindications section.
Besides this, Neugaba 75 Mg Capsule may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Neugaba 75 Mg Capsule is considered not safe while driving, and is not addictive.
Neugaba 75 Mg Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Neugaba 75 Mg Capsule is used -
Moderate
Mild
Is the use of Neugaba 75 Mg Capsule safe for pregnant women?
Pregnant women may experience moderate side effects from Neugaba. It is best to stop taking Neugaba immediately and inform your doctor if you notice any discomfort.
Is the use of Neugaba 75 Mg Capsule safe during breastfeeding?
Neugaba should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Neugaba 75 Mg Capsule on the Kidneys?
Neugaba rarely harms the kidneys.
What is the effect of Neugaba 75 Mg Capsule on the Liver?
Using Neugaba does not have any harmful effects on the liver.
What is the effect of Neugaba 75 Mg Capsule on the Heart?
Neugaba is completely safe for the heart.
Neugaba 75 Mg Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Neugaba 75 Mg Capsule unless your doctor advises you to do so -
Is this Neugaba 75 Mg Capsule habit forming or addictive?
No, you will not get addicted to Neugaba 75 Mg Capsule.
Is it safe to drive or operate heavy machinery when consuming?
After taking Neugaba 75 Mg Capsule you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Neugaba 75 Mg Capsule only as per medical advice.
Is it able to treat mental disorders?
Yes, this Neugaba 75 Mg Capsule works for mental disorders.
Interaction between Food and Neugaba 75 Mg Capsule
You can take Neugaba 75 Mg Capsule with food.
Interaction between Alcohol and Neugaba 75 Mg Capsule
Taking alcohol with Neugaba 75 Mg Capsule can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
